Claudia Altamura1, Angelo Cascio Rizzo2, Giovanna Viticchi3, Paola Maggio4, Carmelina Maria Costa5, Nicoletta Brunelli5, Giuditta Giussani2, Matteo Paolucci5, Fabrizio Fiacco4, Vincenzo Di Lazzaro6, Elio Clemente Agostoni2, Mauro Silvestrini3, Fabrizio Vernieri5. 1. Headache and Neurosonology Unit, Neurology, Università Campus Bio-Medico Di Roma, Campus Bio-Medico University Hospital, Via Alvaro del Portillo, 200, 00128, Rome, Italy. c.altamura@unicampus.it. 2. Neurologia E Stroke Unit ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy. 3. Neurological Clinic, Marche Polytechnic University, Ancona, Italy. 4. UOC Neurologia ASST Bergamo Est, Seriate, Italy. 5. Headache and Neurosonology Unit, Neurology, Università Campus Bio-Medico Di Roma, Campus Bio-Medico University Hospital, Via Alvaro del Portillo, 200, 00128, Rome, Italy. 6. Neurology, Neurophysiology and Neurobiology Unit, Department of Medicine, Università Campus Bio-Medico di Roma, Rome, Italy.
Abstract
OBJECTIVE: To identify the clinical profile and aura characteristics of patients with Migraine with Aura (MwA) having acute cerebral ischemia, we compared stroke phenotype and risk factors in stroke patients with (S+MwA+) or without (S+MwA-) MwA and aura features in MwA patients with (S+MwA+) or without (S-MwA+) stroke. METHODS: In this retrospective multicenter case-control study, we reviewed stroke phenotypes and vascular risk factors in S+MwA+ and S+MwA- patients younger than 60 years and risk factors and aura type, duration, onset age, and the frequency in the previous year in S+MwA+ patients and S-MwA+ subjects matched for age and disease history, investigated for patent foramen ovale (PFO). RESULTS: 539 stroke (7.7% S+MwA+) and 94 S-MwA + patients were enrolled. S+MwA+ patients were younger (p =.0.004) and more frequently presented PFO [OR 4.89 (95% CI 2.12-11.27)], septal interatrial aneurism [OR 2.69 (95% CI 1.15-6.27)] and cryptogenic ischemic stroke (CIS) [OR 6.80 (95% CI 3.26-14.18)] than S+MwA- subjects. Significant atherosclerosis was not detected in S+MwA+ patients. Compared to S-MwA+, S+MwA+ patients were characterized by visual [OR 3.82 (95% CI 1.36-10.66)] and shorter-lasting (20.0 min IQr 13.1 vs 30.0 min IQr 25.0; p < 0.001) aura, and PFO [OR 1.26 (95% CI 1.03-1.54)]. Regression analysis evidenced that only shorter aura duration associated with stroke (p = 0.001). High-risk PFO was equally represented in S+MwA-, S+MwA+, S-MwA+ groups. CONCLUSIONS: Shorter visual aura and CIS characterize MwA patients with stroke. Although more prevalent, PFO can not be considered the main responsible for the increased stroke risk in MwA patients but as a part of a complex multifactorial condition.
OBJECTIVE: To identify the clinical profile and aura characteristics of patients with Migraine with Aura (MwA) having acute cerebral ischemia, we compared stroke phenotype and risk factors in stroke patients with (S+MwA+) or without (S+MwA-) MwA and aura features in MwA patients with (S+MwA+) or without (S-MwA+) stroke. METHODS: In this retrospective multicenter case-control study, we reviewed stroke phenotypes and vascular risk factors in S+MwA+ and S+MwA- patients younger than 60 years and risk factors and aura type, duration, onset age, and the frequency in the previous year in S+MwA+ patients and S-MwA+ subjects matched for age and disease history, investigated for patent foramen ovale (PFO). RESULTS: 539 stroke (7.7% S+MwA+) and 94 S-MwA + patients were enrolled. S+MwA+ patients were younger (p =.0.004) and more frequently presented PFO [OR 4.89 (95% CI 2.12-11.27)], septal interatrial aneurism [OR 2.69 (95% CI 1.15-6.27)] and cryptogenic ischemic stroke (CIS) [OR 6.80 (95% CI 3.26-14.18)] than S+MwA- subjects. Significant atherosclerosis was not detected in S+MwA+ patients. Compared to S-MwA+, S+MwA+ patients were characterized by visual [OR 3.82 (95% CI 1.36-10.66)] and shorter-lasting (20.0 min IQr 13.1 vs 30.0 min IQr 25.0; p < 0.001) aura, and PFO [OR 1.26 (95% CI 1.03-1.54)]. Regression analysis evidenced that only shorter aura duration associated with stroke (p = 0.001). High-risk PFO was equally represented in S+MwA-, S+MwA+, S-MwA+ groups. CONCLUSIONS: Shorter visual aura and CIS characterize MwA patients with stroke. Although more prevalent, PFO can not be considered the main responsible for the increased stroke risk in MwA patients but as a part of a complex multifactorial condition.
Authors: Nicolas Martinez-Majander; Ville Artto; Pauli Ylikotila; Bettina von Sarnowski; Ulrike Waje-Andreassen; Nilufer Yesilot; Marialuisa Zedde; Juha Huhtakangas; Heikki Numminen; Pekka Jäkälä; Ana C Fonseca; Petra Redfors; Marieke J H Wermer; Alessandro Pezzini; Jukka Putaala Journal: Ann Neurol Date: 2020-11-12 Impact factor: 10.422
Authors: V De Giuli; M Grassi; M Locatelli; M Gamba; A Morotti; S Bonacina; V Mazzoleni; D Pezzini; M Magoni; R Monastero; A Padovani; A Pezzini Journal: Eur J Neurol Date: 2020-10-24 Impact factor: 6.089
Authors: Brian H West; Nabil Noureddin; Yakov Mamzhi; Christopher G Low; Alexandra C Coluzzi; Evan J Shih; Rubine Gevorgyan Fleming; Jeffrey L Saver; David S Liebeskind; Andrew Charles; Jonathan M Tobis Journal: Stroke Date: 2018-04-10 Impact factor: 7.914
Authors: Souvik Sen; X Michelle Androulakis; Viktoriya Duda; Alvaro Alonso; Lin Yee Chen; Elsayed Z Soliman; Jared Magnani; Tushar Trivedi; Anwar T Merchant; Rebecca F Gottesman; Wayne D Rosamond Journal: Neurology Date: 2018-11-14 Impact factor: 11.800
Authors: Coline L Lemale; Janos Lückl; Viktor Horst; Clemens Reiffurth; Sebastian Major; Nils Hecht; Johannes Woitzik; Jens P Dreier Journal: Front Cell Neurosci Date: 2022-02-10 Impact factor: 6.147
Authors: Nicoletta Brunelli; Claudia Altamura; Carlo A Mallio; Gianguido Lo Vullo; Marilena Marcosano; Marcel Bach-Pages; Bruno Beomonte Zobel; Carlo Cosimo Quattrocchi; Fabrizio Vernieri Journal: Int J Environ Res Public Health Date: 2022-07-14 Impact factor: 4.614